Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver
Published date: 15 Jul 2020
Copyright
Bingbing He , Wenbo Peng , Jia Huang , Hang Zhang , Yingsi Zhou , Xiali Yang , Jing Liu , Zhijie Li , Chunlong Xu , Mingxing Xue , Hui Yang , Pengyu Huang . Modulation of metabolic functions through Cas13d-mediated gene knockdown in liver[J]. Protein & Cell, 2020 , 11(7) : 518 -524 . DOI: 10.1007/s13238-020-00700-2
1 |
Chan JC, Piper DE, Cao Q, Liu D, King C, Wang W, Tang J, Liu Q, Higbee J, Xia Z
|
2 |
Freije CA, Myhrvold C, Boehm CK, Lin AE, Welch NL, Carter A, Metsky HC, Luo CY, Abudayyeh OO, Gootenberg JS
|
3 |
Haeusler RA, Hartil K, Vaitheesvaran B, Arrieta-Cruz I, Knight CM, Cook JR, Kammoun HL, Febbraio MA, Gutierrez-Juarez R, Kurland IJ
|
4 |
Jackson AL, Bartz SR, Schelter J, Kobayashi SV, Burchard J, Mao M, Li B, Cavet G, Linsley PS (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat Biotechnol 21:635–637
|
5 |
Konermann S, Lotfy P, Brideau NJ, Oki J, Shokhirev MN, Hsu PD (2018) Transcriptome engineering with RNA-targeting type VI-D CRISPR effectors. Cell 173(665–676):e614
|
6 |
Lambert G, Sjouke B, Choque B, Kastelein JJ, Hovingh GK (2012) The PCSK9 decade. J Lipid Res 53:2515–2524
|
7 |
Li P, Ruan X, Yang L, Kiesewetter K, Zhao Y, Luo H, Chen Y, Gucek M, Zhu J, Cao H (2015) A liver-enriched long non-coding RNA, lncLSTR, regulates systemic lipid metabolism in mice. Cell Metab 21:455–467
|
8 |
Moller DE (2012) Metabolic disease drug discovery- “hitting the target” is easier said than done. Cell Metab 15:19–24
|
9 |
Pineda M, Lear A, Collins JP, Kiani S (2019) Safe CRISPR: challenges and possible solutions. Trends Biotechnol 37:389–401
|
10 |
Price AA, Sampson TR, Ratner HK, Grakoui A, Weiss DS (2015) Cas9-mediated targeting of viral RNA in eukaryotic cells. Proc Natl Acad Sci USA 112:6164–6169
|
11 |
Rossidis AC, Stratigis JD, Chadwick AC, Hartman HA, Ahn NJ, Li H, Singh K, Coons BE, Li L, Lv W
|
12 |
Steinberg D, Witztum JL (2009) Inhibition of PCSK9: a powerful weapon for achieving ideal LDL cholesterol levels. Proc Natl Acad Sci USA 106:9546–9547
|
13 |
Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA
|
14 |
Yan WX, Chong S, Zhang H, Makarova KS, Koonin EV, Cheng DR, Scott DA (2018) Cas13d is a compact RNA-targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol Cell 70(327–339):e325
|
15 |
Zhou C, Hu X, Tang C, Liu W, Wang S, Zhou Y, Zhao Q, Bo Q, Shi L, Sun X
|
/
〈 | 〉 |